Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947. (Q44686110)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947. |
scientific article |
Statements
1 reference
Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947. (English)
1 reference
1 reference
1 reference
Silvana Libertini
1 reference
Irma Iacuzzo
1 reference
Giuseppe Perruolo
1 reference
Caterina Ieranò
1 reference
Gunnel Hallden
1 reference
Giuseppe Portella
1 reference
1 October 2008
1 reference
1 reference
14
1 reference
20
1 reference
6505-6514
1 reference
Identifiers
1 reference
1 reference